ZAID JABBAR: Open Payments
NPI 1730351115 · OAK BROOK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$151,670 in 403 payments from 25 companies in 2025. Trend: 2023 $164,435 · 2024 $209,201 · 2025 $151,670
Speaker / faculty: $124,220Travel & lodging: $17,534Food & beverage: $8,796Consulting: $1,100Education: $20
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 154 | $92,414 |
| Novo Nordisk Inc | 37 | $21,086 |
| ABBVIE INC. | 51 | $10,768 |
| Aimmune Therapeutics, Inc. | 22 | $9,714 |
| Medicure Pharma Inc. | 1 | $7,500 |
| Bayer Healthcare Pharmaceuticals Inc. | 31 | $6,361 |
| Currax Pharmaceuticals LLC | 18 | $1,326 |
| Madrigal Pharmaceuticals | 8 | $476 |
| Phathom Pharmaceuticals, Inc. | 7 | $267 |
| RECORDATI_RARE_DISEASES_INC. | 6 | $258 |
Products named: Wegovy, ZENPEP, Zypitamag, VRAYLAR, Kerendia, ZEPBOUND, QULIPTA, CONTRAVE.
Industry payments across IL — which companies pay providers there.
